The RELIEF study is a prospective, multi-center, global registry of Boston Scientific neurostimulation systems for pain.
The goal of the RELIEF study is to collect information about adult chronic pain patients who are using a Boston Scientific neurostimulation system.
Who may be eligible to participate?
Adults with chronic low back pain or chronic leg pain who is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain.
Eligible subjects must be 18 years of age or older. Other inclusion and exclusion criteria may apply.
What does participation involve?
If it is determined that you have met all of the study requirements and are willing to participate in the study, you will:
- Be required to provide data at a Baseline, Trial and Implant visit.
- Be asked to complete pain drawings and questionnaires related to your experience with pain
- Be scheduled for follow-up visits at your study doctor’s office: 6, 12, 24 and 36 months after your trial procedure.
- You may receive compensation for your participation in this study.
Jennifer M Lee, MD, EvergreenHealth Pain Care